GlassScriptPhysician profile
Olivia Mae Sutton
NPI 1689135428
$6,583.07
in general payments reported to CMS, 2019-2025
9 companies · $1,049 in 2025
The $1,049 reported for 2025 was more than what 94% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $1,791 · 2024: $3,743 · 2025: $1,049.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,369 · Travel and Lodging: $3,214.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,369.10 |
| Travel and Lodging | $3,213.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $3,279.73 | 2023-2025 | Wavewriter Alpha Prime 16, Artisan, Vercise |
| Medtronic, INC. | $1,619.48 | 2023-2025 | Intellis Adaptivestim, Inceptiv, Synchromedii |
| Abbott Laboratories | $673.94 | 2024 | Proclaim, Eterna, Axium |
| Biotronik Nro, INC. | $390.69 | 2024-2025 | Prospera |
| Saluda Medical Americas, INC. | $337.04 | 2024-2025 | Evoke |
| Vertos Medical, INC. | $174.49 | 2024 | Mild Device Kit |
| Si-Bone, INC. | $52.13 | 2024 | |
| Abbvie INC. | $31.17 | 2024 | |
| Stryker Corporation | $24.40 | 2024 | Mild Device Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olivia Sutton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.